Marshall Wace North America’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Marshall Wace North America’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$291K	Sell	4,012 -64	-2%	-$4.63K	﹤0.01%	1254
2021 Q2	$343K	Buy	+4,076	New	+$269K	﹤0.01%	1255
2021 Q1	–	Sell	-7,564	Closed	-$356K	–	1623
2020 Q4	$356K	Buy	+7,564	New	+$298K	﹤0.01%	1147

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Cederberg Capital London, United Kingdom $100M AUM 90.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ZAM

Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Marshall Wace North America's NBP Position: Q3 2021 in Review

Marshall Wace North America reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 1.6% in Q3 2021, selling an estimated $4.63K and leaving 4,012 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

Marshall Wace North America first reported a position in NBP in Q4 2020 and has held it in 3 quarters since. The position peaked at $356K in Q4 2020. 144 funds tracked by Wall St. Rank hold NBP as of Q3 2021.

Marshall Wace North America held 4,012 shares of NovaBridge Biosciences American Depositary Shares worth $291K as of Q3 2021.
Marshall Wace North America sold 64 NovaBridge Biosciences American Depositary Shares shares in Q3 2021, an estimated $4.63K.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1254 holding.
Marshall Wace North America first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 3 quarters since.
Marshall Wace North America's NovaBridge Biosciences American Depositary Shares position peaked at $356K in Q4 2020.
144 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.